Boston Scientific (BSX) Amortization of Deferred Charges (2020 - 2026)

Boston Scientific has reported Amortization of Deferred Charges for 7 years, with the latest figure at $4.0 million in Q2 2026.

• Amortization of Deferred Charges for Q2 2026 came in at $4.0 million, down 89.19% year-over-year; the trailing twelve-month figure through Jun 2026 was $20.0 million (down 88.17% YoY), and the FY2025 annual result was $132.0 million, up 158.82% from the prior year.
• Amortization of Deferred Charges advanced to $4.0 million in Q2 2026, from $2.0 million in the prior quarter.
• Over five years, Amortization of Deferred Charges peaked at $81.0 million in Q1 2025 and troughed at $2.0 million in Q1 2026.
• A 5-year average of $18.9 million and a median of $7.5 million in 2022 frame the typical range for Amortization of Deferred Charges.
• The widest annual swing landed in 2022, when Amortization of Deferred Charges soared 112.5%; it then slumped 97.53% in 2026.
• A 5-year view of Amortization of Deferred Charges shows it stood at $7.0 million in 2022, then tumbled by 57.14% to $3.0 million in 2023, then jumped by 1600.0% to $51.0 million in 2024, then plunged by 90.2% to $5.0 million in 2025, then slipped by 20.0% to $4.0 million in 2026.
• Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $4.0 million in Q2 2026, $2.0 million in Q1 2026, and $5.0 million in Q4 2025.